Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction

Pharmacogenomics Journal

Volumn 13, Issue 2, 2013, Pages 189-196

  Muniz, J J ^a   Lacchini, R ^b   Rinaldi, T O ^b   Nobre, Y T D A ^b   Cologna, A J ^b   Martins, A C P ^b   Tanus Santos, J E ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

eNOS; erectile dysfunction; haplotype; polymorphisms; prostatectomy; sildenafil

Indexed keywords

ASPARAGINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMINE; SILDENAFIL;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; ERECTILE DYSFUNCTION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATECTOMY; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, PHARMACOLOGICAL; ERECTILE DYSFUNCTION; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; PIPERAZINES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATECTOMY; PURINES; QUESTIONNAIRES; SULFONES;

EID: 84884212207     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2011.49     Document Type: Article

References (38)

1. McVary KT. Clinical practice. Erectile dysfunction. N Engl J Med 2007; 357: 2472-2481.
2. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251-253.
3. Kloner R. Erectile dysfunction and hypertension. Int J Impot Res 2007; 19: 296-302.
4. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A et al. Common grounds for erectile dysfunction and coronary artery disease. Curr Opin Urol 2004; 14: 361-365.
5. Mills JN, Barqawi A, Koul S, Koul H, Meacham RB. The molecular basis of erectile dysfunction: from bench to bedside. Rev Urol 2005; 7: 128-134.
6. Awad A, Alsaid B, Bessede T, Droupy S, Benoit G. Evolution in the concept of erection anatomy. Surg Radiol Anat 2011; 33: 301-312.
7. Marien T, Sankin A, Lepor H. Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy. J Urol 2009; 181: 1817-1822.
8. Toda N, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol Ther 2005; 106: 233-266.
9. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24: S17-S37.
10. Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 2006; 5: 689-702.
11. Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 2005; 96: 257-280.
12. Sandner P, Hutter J, Tinel H, Ziegelbauer K, Bischoff E. PDE5 inhibitors beyond erectile dysfunction. Int J Impot Res 2007; 19: 533-543.
13. Metzger IF, Sertorio JTC, Tanus-Santos JE. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 2007; 43: 987-992.
14. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA et al. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 2005; 15: 565-570.
15. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE. Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J 2011; 11: 393-399.
16. Lee Y-C, Wu W-J, Liu C-C, Wang C-J, Li W-M, Huang C-H et al. The associations among eNOS G894T gene polymorphism, erectile dyseNOS function, and benign prostate hyperplasia-related lower urinary tract symptoms. J Sex Med 2009; 6: 3158-3165.
17. Rosas-Vargas H, Coral-Vazquez RM, Tapia R, Borja JL, Salas RA, Salamanca F. Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population. J Androl 2004; 25: 728-732.
18. Safarinejad MR, Khoshdel A, Shekarchi B, Taghva A, Safarinejad S Association of the T-786C, G894T and a/4b polymorphisms of the endothelial nitric oxide synthase gene with vasculogenic erectile dysfunction in Iranian subjects. BJU Int 2011; 107: 1994-2001.
19. Erol B, Bozdogan G, Akduman B, Dursun A, Bozdogan S, Onem K et al. eNOS gene intron 4 VNTR and exon 7-G894T polymorphisms in Turkish men with erectile dysfunction: a case control study. J Sex Med 2009; 6: 1423-1429.
20. Sinici I, Guven EO, Serefoglu E, Hayran M. T-786C polymorphism in promoter of eNOS gene as genetic risk factor in patients with erectile dysfunction in Turkish population. Urology; 75: 955-960.
21. Napoli C, Ignarro LJ. Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J Clin Pathol 2007; 60: 341-344.
22. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE. Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 2006; 186: 428-432.
23. Sandrim VC, de Syllos RWC, Lisboa HRK, Tres GS, Tanus-Santos JE. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 2006; 189: 241-246.
24. Sandrim VC, de Syllos RWC, Lisboa HRK, Tres GS, Tanus-Santos JE. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 2007; 16: 348-355.
25. Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med, 41, 1044-1049.
26. Lacchini R, Silva PS, Tanus-Santos JE. A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 2010; 106: 357-361.
27. Peskircioglu L, Atac FB, Erdem SR, Deveci S, Verdi H, Ozkardes H. The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res 2007; 19: 149-153.
28. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
29. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001; 11: 719-725.
30. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a-786T-4C mutation associated with coronary spastic angina. Hum Mol Genet, 9, 2629-2637
31. Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Chen L et al. Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell 2008; 19: 3997-4005.
32. Joshi MS, Mineo C, Shaul PW, Bauer JA. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 2007; 21: 2655-2663.
33. Podlasek CA, Gonzalez CM, Zelner DJ, Jiang HB, McKenna KE, McVary KT. Analysis of NOS isoform changes in a post radical prostatectomy model of erectile dysfunction. Int J Impot Res 2001; 13(Suppl 5): S1-15.
34. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005; 12: 177-182.
35. Luizon MR, Izidoro-Toledo TC, Simoes AL, Tanus-Santos JE. Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians. DNA Cell Biol 2009; 28: 329-334.
36. Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE. Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis; 193: 438-444.
37. Sandrim VC, Palei AC, Luizon MR, Izidoro-Toledo TC, Cavalli RC, Tanus-Santos JE. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Pharmacogenomics J 2010; 10: 40-45.
38. Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. Eur J Pharmacol 2004; 498: 189-194.